PLUR - Pluristem Therapeutics Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

11.53M

Cash

40.17M

Avg Qtr Burn

-5.714M

Short % of Float

0.20%

Insider Ownership

15.13%

Institutional Own.

5.75%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
PLX-PAD Details Muscle injury following hip fracture	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PLX-R18 Details Acute radiation syndrome	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PLX-PAD Details COVID-19, Hematopoietic cell transplantation	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PLX-R18 Details Incomplete hematopoietic recovery following	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PLX-PAD (stem cells) Details Critical limb ischemia	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.